Who owns Gilead Sciences Inc?

It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA. GILD | Complete Gilead Sciences Inc. stock news by MarketWatch.

Is Gilead a good stock to buy?

Across all products, Gilead's sales declined 5% to $7 billion. But that was far better than estimates for $6.13 billion, according to GILD stock analysts polled by FactSet. Adjusted earnings skidded 28% to $1.90 per share but topped forecasts for $1.43.

Does Gilead Sciences (gild) pay a dividend?

Gilead Sciences (NASDAQ:GILD) pays an annual dividend of $3.08 per share and currently has a dividend yield of 4.60%. GILD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.